EuBiologics Co., Ltd.
Develops vaccines for global public health and provides biopharmaceutical CRMO services.
206650 | KO
Overview
Corporate Details
- ISIN(s):
- KR7206650004
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 도산대로 509 13층,15층, 서울특별시
- Website:
- http://eubiologics.com/eng/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
EuBiologics Co., Ltd. is a global biopharmaceutical company dedicated to improving public health. The company operates through two primary business segments: Product Development and Contract Research and Manufacturing Organization (CRMO) services. In its product division, EuBiologics develops and supplies safe, effective vaccines for global public health, with a strategic focus on preventing epidemics in developing countries. It is a key global supplier of the WHO-prequalified oral cholera vaccine, Euvichol®. As a CRMO, the company provides specialized, end-to-end services for microbial- and mammalian cell-derived biopharmaceuticals, from cell line development to commercial production. EuBiologics operates advanced bio-manufacturing facilities that comply with international GMP regulations and guidelines, emphasizing technological innovation and adherence to the highest safety and quality standards.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-13 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.0 MB | ||
| 2025-07-31 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (유티프씨주멀티도즈(수출용) 백신의 한국 품목허가 승인)
|
Korean | 12.0 KB | ||
| 2025-06-30 00:00 |
Share Issue/Capital Change
[기재정정]신규시설투자등(자율공시)
|
Korean | 12.7 KB | ||
| 2025-05-13 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 845.5 KB | ||
| 2025-05-02 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 7.0 KB | ||
| 2025-04-15 00:00 |
Regulatory News Service
단일판매ㆍ공급계약체결(자율공시)
|
Korean | 8.9 KB | ||
| 2025-04-07 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-04-07 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.9 KB | ||
| 2025-04-07 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-04-01 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-03-26 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 24.7 KB | ||
| 2025-03-26 00:00 |
Board/Management Information
대표이사변경
|
Korean | 10.5 KB | ||
| 2025-03-18 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 18.7 KB | ||
| 2025-03-18 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 620.5 KB | ||
| 2025-03-18 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
|
Korean | 255.4 KB |
Automate Your Workflow. Get a real-time feed of all EuBiologics Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EuBiologics Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EuBiologics Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}